Sanofi SA Q2 2017 Earnings Call Transcript - Thomson StreetEvents

Sanofi SA Q2 2017 Earnings Call Transcript

Sanofi SA Q2 2017 Earnings Call Transcript - Thomson StreetEvents
Sanofi SA Q2 2017 Earnings Call Transcript
Published Jul 31, 2017
20 pages (13184 words) — Published Jul 31, 2017
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of SASY.PA earnings conference call or presentation 31-Jul-17 12:30pm GMT

  
Brief Excerpt:

...Alan Main;Executive Vice President of Consumer Healthcare David Loew;Executive Vice President of Sanofi Pasteur Elias Zerhouni;Head of Global Research & Development George Grofik;Vice President, Head of Investor Relations Jerome Contamine;CFO & Executive VP Olivier Charmeil ...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Sanofi SA
Ticker
SASY.PA
Time
12:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Philippe Lanone - Natixis S.A., Research Division - Analyst : And a question first on Dupixent. So the 7,000 prescribers target, which was mentioned initially with -- about people -- doctors who already were used to prescribe biologics especially Cosentyx. So I wonder what would be the total dermatologist pool that you can aim beyond the 7,000? That's the first question. The second one, could you clarify on the guidance you gave for the second half on diabetes, saying that it would be worse. Is it worse than the first half or than the second quarter? Or can we take the second quarter maybe as a proxy for second half in terms of rate of decline? And maybe last question on Lovenox, which in Europe is beginning to decline due to biosimilars. So could you give us an indication of what kind of a patent decline we should expect and if there will be several biosimilars? Olivier Brandicourt;Director Thank you, Philippe. We're starting with Dupixent again, 7,000 target. How much more dermatologist is there?

Table Of Contents

Sanofi SA at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-15 – US$ 54.00 – Edited Transcript of SASY.PA presentation 15-Sep-20 6:45pm GMT

Sanofi SA To Acquire Principia Biopharma Inc - M&A Call Transcript – 2020-08-17 – US$ 54.00 – Edited Transcript of SASY.PA M&A conference call or presentation 17-Aug-20 1:00pm GMT

Sanofi SA Nirsevimab R&D Investor Event Transcript – 2020-07-30 – US$ 54.00 – Edited Transcript of SASY.PA conference call or presentation 30-Jul-20 3:00pm GMT

Sanofi SA Q2 2020 Earnings Call Transcript – 2020-07-29 – US$ 54.00 – Edited Transcript of SASY.PA earnings conference call or presentation 29-Jul-20 12:30pm GMT

Sanofi SA Q2 2017 Earnings Call Summary – 2017-07-31 – US$ 54.00 – Edited Brief of SASY.PA earnings conference call or presentation 31-Jul-17 12:30pm GMT

Sanofi SA at Leerink Swann Global Healthcare Conference Transcript – 2013-02-14 – US$ 54.00 – Edited Transcript of SASY.PA presentation 14-Feb-13 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Sanofi SA Q2 2017 Earnings Call Transcript" Jul 31, 2017. Alacra Store. May 24, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2017-Sanofi-SA-Earnings-Call-T10550671>
  
APA:
Thomson StreetEvents. (2017). Sanofi SA Q2 2017 Earnings Call Transcript Jul 31, 2017. New York, NY: Alacra Store. Retrieved May 24, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2017-Sanofi-SA-Earnings-Call-T10550671>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.